TickerTalks
Browse all tickers →
TickerTalks›$WALD
WAWALD

Waldencast plc

$WALD·$205M·Household & Personal Products·Consumer Defensive
$1.37+2.2%YTD-18.1%1Y-15.2%
Mentions · last 7 days
2026-08-21: 1 posts2026-08-22: 1 posts5+25%
Price updated just now·X counts updated 9d ago
WAWALD
$WALDWaldencast plc
$1.37+2.24%5 posts+25%
AI analysisFundamentalsVoices on X
Loading…

AI verdict & sentimentAI analysisGenerated by AI from underlying data

Today's AI verdict on what's driving $WALD, plus how loud the X conversation is and which way it's leaning.

AI analysis

TickerTalks’ read on the fundamentals and what’s driving the move.

Broken storySelling offAI verdict · as of 2026-08-21

Falling on heavy selling — points lower unless it turns around.

Beauty-and-wellness roll-up sold Obagi, the original SPAC sponsors exited fully, and Q2 hits tomorrow — the story has shed both a leg and its backers.

Waldencast is a beauty and wellness holding company that owned Milk Makeup and Obagi Medical. The setup is now a shell of the original 2021 SPAC pitch: Obagi was sold to Bridgepoint on July 30, and the original SPAC sponsors (Beauty Ventures LLC and Waldencast Long-Term Capital) filed a 13D/A on June 26 disclosing a full exit from their positions.

  • Sale of Obagi Medical to Bridgepoint closed on July 30 — the divestiture removes the medical-aesthetic scale asset and turns Waldencast into a pure-play smaller Milk Makeup story with unclear standalone economics.
  • Original SPAC sponsors reported 0 shares as of June 24 in the second and final 13D/A amendment — a total sponsor exit is one of the most bearish possible signals for a post-SPAC equity, especially concurrent with a divestiture.
  • Q2 earnings hit Aug 21 with consensus at negative $0.17 EPS — the last four surprises (-200%, -20%, -215%, 0%) have been ugly, and the market's tolerance for another headline miss is minimal at this point in the story.
  • Trades at $1.35 (18% year-to-date decline), 25% of the 52-week range, and negative TTM PE with roughly 48% return on equity negative — the multiples reflect the going-concern discount, not a specific fundamental read.

What changes the picture is a specific Milk Makeup revenue acceleration or a strategic-review announcement (sale of the remaining asset). What accelerates the breakdown is another EPS miss on Aug 21 or a Nasdaq compliance issue at these prices; the sponsor exit plus Obagi divestiture plus the earnings-miss pattern is a hard combination to be constructive on.

What to watch: Aug 21 Q2 earnings (today) — consensus negative $0.17 EPS. Watch Milk Makeup standalone revenue growth, use of proceeds from the Obagi sale, and any specific strategic-review commentary.

On the calendar: 2026-08-21 — Q2 earnings (today)

float missing

Read the AI verdict + X sentiment for $WALD

  • One-line verdict on what's driving the move — fundamentals, momentum, both, or an event
  • Next dated catalyst when there is one (earnings, deal closing, activist clock)
  • X crowd read with bullish/bearish call + post volume
Free, forever. No credit card.

What it does

Plain-English summary of the business — what they sell and how they make money.

Owns and markets dermatological skincare brands Obagi Medical and Milk Makeup targeting medical and mass consumer beauty markets.

Industry overviewAI analysisGenerated by AI from underlying data

Where Household & Personal Products sits in its cycle right now — and what that implies for $WALD.

Household & Personal Products · Consumer Defensive

Consumer staples demand is resilient but volume-flat; pricing power from inflation-era increases is normalizing, and promotional intensity is picking up. Emerging market growth is the incremental topline driver as developed markets plateau.

What this means for $WALD

Partial — software subscription economics provide some insulation from macro cycles; AI integration is the growth catalyst for this segment; Waldencast Plc develops and operates a beauty and wellness p.

Industry benchmark

12-name peer basket
-0.3%YTD
-14.2%1Y

Fundamentals & catalyst

Profitability, valuation, and the next earnings event — at a glance, with rule-of-thumb signals.

Key ratios

P/E
-0.9How much investors are paying per dollar of profit the company actually earned in the last 12 months. Lower means the stock looks cheaper relative to earnings.~15–25 is typical for the S&P 500; high-growth names trade 30+; hyper-growth or speculative can be 100+ or negative.
ROIC
-7.8%What percentage return the business earns on every dollar of capital (equity + debt) deployed in operations. The cleanest measure of business quality.Above ~15% is high-quality; consistently above 25% suggests a real moat. Below the company's cost of capital is value-destroying.
Op margin
-22.7%Operating profit (after sales, marketing, R&D, and overhead but before interest and taxes) as a percentage of revenue. The clearest view of how well the underlying business is run.Mature business above 20% is healthy; software businesses can run 30%+; commodity / retail businesses operate in single digits.
FCF yield
-8.0%Free cash flow (operating cash flow minus capex) divided by the company's market cap. The cash-on-cash return you'd get owning the whole business at today's price.Above ~5% is attractive; below ~2% means you're paying up for growth. Capital-light businesses (software) run higher than capital-heavy ones (utilities).
P/S
0.7Same idea as P/E but per dollar of revenue. Useful for companies that aren't profitable yet, where P/E is meaningless.Under ~2 is cheap; software / SaaS often runs 8–15; well above 20 implies the market is pricing in very high future growth.
ROE
-47.8%Net income as a percentage of shareholders' equity. Similar to ROIC but counts only the equity side.Above 20% is strong, but can be inflated by leverage — a heavily indebted company can show high ROE with weak underlying ROIC.
Gross margin
45.5%Revenue minus the direct cost of producing what was sold, as a percentage of revenue. The first read on whether the product is structurally profitable.Software / SaaS is typically 70%+; consumer goods 30–50%; commodity / hardware businesses can be under 20%.
D/E
0.3Total debt divided by shareholders' equity. Measures how much the business runs on borrowed money versus owner capital.Under 1 is conservative; 1–2 is typical for mature businesses; over 2 is leveraged and more sensitive to interest rates.

Past earnings

QuarterReportedActualEstimateSurprise
Q4 2025Mar 13, 2026$-0.51$-0.17-200.0%
Q4 2025Jan 13, 2026$-0.09$-0.07-20.0%
Q1 2025May 13, 2025$-0.17$-0.05-214.8%
Q3 2024Nov 20, 2024$-0.05$-0.050.0%
Next earningsTue, Sep 1·consensus EPS $-0.17

Quarterly trend

QuarterRevenueYoYGrossOpEPSFCF
Q4 FY25$139.8M+28.5%43.9%-21.7%$-0.51$-2.2M
Q2 FY25$132.3M+21.0%47.2%-23.7%$-1.51$-14.1M
Q4 FY24$142.3M+58.4%68.6%-21.8%$-0.29$1.1M
Q2 FY24$131.6M+72.5%71.6%-20.9%$-0.09$-12.7M

Forward consensus

2-year forecast · up to 2 analysts
FYRevenueRangeEPSRangeAnalysts
FY26$291.9M$290.0M – $293.0M-$0.61-$0.62 – -$0.612
FY27$306.4M$304.4M – $307.6M-$0.58-$0.58 – -$0.582

Setup & momentum

Volume, range, and moving-average position — the technical setup driving short-term moves.

Right now

Vol vs 30dToday's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.0.1×Today's traded share volume divided by the average over the prior 30 trading days. ≥3× signals unusual interest; below 1× is quiet.
52w rangeWhere the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.25%Where the latest close sits between the 52-week low (0%) and high (100%). Above 80% is extended; below 30% is basing or in a downtrend.
vs 50d MALatest close vs the 50-day simple moving average. Positive = short-term trend is up.-14.1%Latest close vs the 50-day simple moving average. Positive = short-term trend is up.
vs 200d MALatest close vs the 200-day simple moving average. Positive = long-term trend is up.-16.4%Latest close vs the 200-day simple moving average. Positive = long-term trend is up.

Float & profile

FloatLow float · 12.5M shFree-float shares — the slice of issued stock actually available to trade. Lower buckets squeeze harder on a catalyst.Traded today0.2% of floatToday's volume as a percent of the free float. Above 5% on a single day is unusually high turnover for the available share count.β-0.045-year weekly beta vs the S&P 500. Above 1.5 means the stock typically moves more than the index; below 0.8 moves less.

Insider activity

Recent open-market buys and sells by officers and directors — flagged when multiple insiders cluster.

Recent transactions

No open-market buys or sells in the last 180 days.

+ 3 other (2 returns · 1 exempt) in window

See when $WALD insiders are putting their own money in

  • Real-time open-market buys and sells from Form 4 filings
  • Cluster-buy detection when multiple insiders pile in at once
  • 30 / 60 / 180-day windows so you can spot building conviction
Free, forever. No credit card.

SEC filings

Material 8-K, 13D, S-3, and 424B5 events from the last 180 days — the filings that actually move the price.

Recent material filings

SC 13D/AActivist amendmentJun 26SC 13D/A
AI summary

Waldencast — Beauty Ventures LLC and Waldencast Long-Term Capital both reported 0 shares of Waldencast PLC as of June 24, 2026, reflecting a full exit from their prior positions. The original SPAC sponsors and founding entities have completely exited their economic interest in Waldencast; this is the second and final 13D/A amendment reflecting the full wind-down of sponsor positions.

3New insider — initial holdingsMar 183
AI summary

Form filed by More than One Reporting Person Table I - Non-De filed a Form 3 (initial ownership statement) for WALD on 2026-03-18, initiating required Section 16 reporting. Role: of Reporting Person. Form 3 is a mandatory administrative filing upon first becoming an insider or 10%+ holder; it does not reflect a purchase or sale event.

3New insider — initial holdingsMar 183
AI summary

Form filed by More than One Reporting Person Table I - Non-De filed a Form 3 (initial ownership statement) for WALD on 2026-03-18, initiating required Section 16 reporting. Role: of Reporting Person. Form 3 is a mandatory administrative filing upon first becoming an insider or 10%+ holder; it does not reflect a purchase or sale event.

3New insider — initial holdingsMar 183
AI summary

Form filed by More than One Reporting Person Table I - Non-De filed a Form 3 (initial ownership statement) for WALD on 2026-03-18, initiating required Section 16 reporting. Role: of Reporting Person. Form 3 is a mandatory administrative filing upon first becoming an insider or 10%+ holder; it does not reflect a purchase or sale event.

3New insider — initial holdingsMar 183
AI summary

Form filed by More than One Reporting Person Table I - Non-De filed a Form 3 (initial ownership statement) for WALD on 2026-03-18, initiating required Section 16 reporting. Role: of Reporting Person. Form 3 is a mandatory administrative filing upon first becoming an insider or 10%+ holder; it does not reflect a purchase or sale event.

3New insider — initial holdingsMar 183
AI summary

Form filed by More than One Reporting Person Table I - Non-De filed a Form 3 (initial ownership statement) for WALD on 2026-03-18, initiating required Section 16 reporting. Role: of Reporting Person. Form 3 is a mandatory administrative filing upon first becoming an insider or 10%+ holder; it does not reflect a purchase or sale event.

3New insider — initial holdingsMar 183
AI summary

Form filed by More than One Reporting Person Table I - Non-De filed a Form 3 (initial ownership statement) for WALD on 2026-03-18, initiating required Section 16 reporting. Role: of Reporting Person. Form 3 is a mandatory administrative filing upon first becoming an insider or 10%+ holder; it does not reflect a purchase or sale event.

3New insider — initial holdingsMar 183
AI summary

Form filed by More than One Reporting Person Table I - Non-De filed a Form 3 (initial ownership statement) for WALD on 2026-03-18, initiating required Section 16 reporting. Role: of Reporting Person. Form 3 is a mandatory administrative filing upon first becoming an insider or 10%+ holder; it does not reflect a purchase or sale event.

+ 13 other (9 6-Ks · 2 3s · 1 13G · 1 20-F) in window

Recent news

Latest headlines from major outlets, sourced and timestamped — context for whatever just moved.

Waldencast Announces Completion of the Sale of Obagi Medical to Bridgepointglobenewswire.com·32d agoObagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gelglobenewswire.com·77d agoWaldencast Announces Sale of Obagi Medical to Bridgepointglobenewswire.com·91d ago

More in Household & Personal Products

Peers in the same group — one click to compare setups, fundamentals, and chatter.

$EL$CL$ELF$PG$COTY$KMB$KVUE$CLX
Voices on X · last 7 days

No standout posts about $WALD on X in the last 7 days.

TickerTalks is a research tool, not financial advice. We surface social-attention data; we do not make stock recommendations. Past attention is not predictive of future price movements.

PrivacyTermsSupport